SCHEMBL14615964

SCHEMBL14615964

COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)OCOC(=O)O)cn(C3CC3)c12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.79
HPGD P15428 6/20 0.79
ALDH1A1 P00352 6/20 0.79
HSD17B10 Q99714 4/20 0.79
KCNH2 Q12809 3/20 0.79
TDP1 Q9NUW8 3/20 0.79
POLB P06746 2/20 0.79
PRKD3 O94806 1/20 0.79
ALOX15 P16050 1/20 0.79
OPRM1 P35372 1/20 0.79
CLK2 P49760 1/20 0.79
CLK4 Q9HAZ1 1/20 0.79
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.55
NPSR1 Q6W5P4 1/20 0.53
CYP2C19 P33261 1/20 0.53
ATM Q13315 1/20 0.52
PMP22 Q01453 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5009616 0.90 KDM4E (0.75) KDM4EHPGDALDH1A1HSD17B10KCNH2
SCHEMBL16010307 0.90 KDM4E (0.78) KDM4EHPGDALDH1A1HSD17B10KCNH2
SCHEMBL16009404 0.90 KDM4E (0.82) KDM4EHPGDALDH1A1HSD17B10KCNH2
SCHEMBL15132795 0.89 KDM4E (0.85) KDM4EHPGDALDH1A1HSD17B10KCNH2
SCHEMBL16008951 0.89 KDM4E (0.77) KDM4EHPGDALDH1A1HSD17B10KCNH2
Gatifloxacin SCHEMBL2224369 0.89 KDM4E (1.00) KDM4EHPGDALDH1A1HSD17B10KCNH2
Gatifloxacin SCHEMBL29356306 0.89 KDM4E (1.00) KDM4EHPGDALDH1A1HSD17B10KCNH2
Gatifloxacin SCHEMBL22591 0.89 KDM4E (1.00) KDM4EHPGDALDH1A1HSD17B10KCNH2
(R)-Gatifloxacin SCHEMBL5670068 0.89 KDM4E (1.00) KDM4EHPGDALDH1A1HSD17B10KCNH2
(S)-Gatifloxacin SCHEMBL30910969 0.89 KDM4E (1.00) KDM4EHPGDALDH1A1HSD17B10KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007017762-A2 PHOSPHONATED FLUOROQUINOLONES, ANTIBACTERIAL ANALOGS THEREOF, AND METHODS FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS TARGANTA THERAPEUTICS INC. (CA) 2007-02-15 WO disclosed